Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $620.47 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $160.51 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $154.97 | 9 | $0 (2021) |
| Relypsa, Inc. | $83.31 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $62.24 | 4 | $0 (2020) |
| Lilly USA, LLC | $48.98 | 3 | $0 (2020) |
| Novo Nordisk Inc | $25.96 | 2 | $0 (2019) |
| Corcept Therapeutics | $22.50 | 1 | $0 (2020) |
| SANOFI PASTEUR INC. | $21.45 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.26 | 1 | $0 (2020) |
| PFIZER INC. | $13.05 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $18.18 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18.18) |
| 2020 | $87.31 | 5 | Lilly USA, LLC ($35.91) |
| 2019 | $256.42 | 9 | AstraZeneca Pharmaceuticals LP ($146.26) |
| 2018 | $61.59 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($35.75) |
| 2017 | $196.97 | 9 | Relypsa, Inc. ($83.31) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: DIABETES | ||||||
| 11/19/2020 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Neuroscience | ||||||
| 09/10/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Diabetes | ||||||
| 04/22/2020 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Endocrinology | ||||||
| 03/17/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/18/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2019 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), FLUBLOK QUADRIVALENT, PENTACEL | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: VACCINES | ||||||
| 08/27/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Diabetes | ||||||
| 07/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: DIABETES | ||||||
| 06/27/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Diabetes | ||||||
| 05/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: DIABETES | ||||||
| 02/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2019 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: VACCINES | ||||||
| 11/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY XR | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: DIABETES | ||||||
| 10/31/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: VACCINES | ||||||
| 07/25/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/29/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: DIABETES | ||||||
| 11/09/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Diabetes | ||||||
| 11/07/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: DIABETES | ||||||
| 08/30/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: DIABETES | ||||||
| 08/23/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 186 | 269 | $19,715 | $12,660 |
| 2022 | 7 | 247 | 389 | $26,918 | $16,775 |
| 2021 | 9 | 342 | 503 | $30,381 | $19,266 |
| 2020 | 9 | 330 | 474 | $34,034 | $18,975 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 110 | $10,670 | $6,852 | 64.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 23 | $3,473 | $2,066 | 59.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $2,101 | $2,059 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 25 | $1,800 | $835.52 | 46.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 74 | $740.00 | $621.60 | 84.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 19 | $931.00 | $225.91 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 142 | $13,774 | $9,023 | 65.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $2,802 | $2,758 | 98.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 30 | $4,530 | $2,566 | 56.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 39 | 51 | $3,672 | $1,666 | 45.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 59 | 116 | $1,160 | $344.04 | 29.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $245.82 | $238.42 | 97.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 15 | $735.00 | $178.26 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 148 | $14,356 | $9,038 | 63.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 73 | 99 | $7,128 | $3,779 | 53.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 27 | 27 | $3,152 | $3,152 | 100.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 12 | $1,812 | $1,196 | 66.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 15 | 15 | $1,155 | $996.45 | 86.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 25 | $499.50 | $447.54 | 89.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 74 | 143 | $1,430 | $429.00 | 30.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 15 | $735.00 | $161.72 | 22.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 13 | 19 | $114.00 | $66.12 | 58.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 98 | 188 | $18,236 | $9,900 | 54.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 44 | $6,644 | $3,445 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 23 | 23 | $2,685 | $2,673 | 99.6% |
About Dr. Peyton Riggs, DO
Dr. Peyton Riggs, DO is a Family Medicine healthcare provider based in Tehachapi, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245232685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peyton Riggs, DO has received a total of $620.47 in payments from pharmaceutical and medical device companies, with $18.18 received in 2021. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($620.47).
As a Medicare-enrolled provider, Riggs has provided services to 1,105 Medicare beneficiaries, totaling 1,635 services with total Medicare billing of $67,675. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Tehachapi, CA
- Active Since 08/15/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1245232685
Products in Payments
- FARXIGA (Drug) $160.51
- JARDIANCE (Drug) $138.62
- Veltassa (Drug) $83.31
- JANUVIA (Drug) $62.24
- TRADJENTA (Drug) $52.42
- Korlym (Drug) $22.50
- FLUZONE HIGH-DOSE (Drug) $21.45
- XIFAXAN (Drug) $15.26
- Tresiba (Drug) $15.18
- PREVNAR - 13 (Biological) $13.05
- EMGALITY (Drug) $12.91
- SHINGRIX (Biological) $12.24
- Victoza (Drug) $10.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tehachapi
Zachary Taylor, Fnp-C, FNP-C
Family Medicine — Payments: $945.04
Dr. Susan Cribbs, Do, DO
Family Medicine — Payments: $864.00
Dr. Patrick O'connell, M.d, M.D
Family Medicine — Payments: $857.79
Dr. Susan Hall, M.d, M.D
Family Medicine — Payments: $592.36
Dr. Kim Horowitz, M.d, M.D
Family Medicine — Payments: $257.19
Michael Santillanes
Family Medicine — Payments: $146.80